[Roche](https://www.gene.com/good/giving/corporate-giving)

Rolling

Not specified; funding and partnership terms are negotiated based on project scope and collaboration model.

Roche seeks innovative partners to advance breakthrough science and transformative healthcare solutions across diverse therapeutic and technology domains.

--- ## Description Roche is actively seeking partnerships with organizations and innovators who are passionate about pioneering science and share a vision to improve patient health. The company emphasizes collaborative, trust-based relationships with partners to invent new drugs or accelerate programs that can revolutionize standards of care. Roche’s partnering interests span a wide range of therapeutic areas, including cardiovascular, renal and metabolic diseases, oncology and hematology, immunology, infectious diseases, neurology, ophthalmology, research technologies, and digital/data solutions. The company is open to proposals from academic institutions, biotech companies, and other organizations with best- or first-in-class innovations. --- ## Due Dates - Rolling submissions; proposals are accepted year-round. --- ## Funding Amount - Funding amount is not specified in advance. - Partnership terms, including financial support, are negotiated on a case-by-case basis depending on the project scope, stage of development, and collaboration model (e.g., research collaboration, co-development, acquisition, licensing). --- ## Eligibility - Eligible applicants include: - Academic institutions - Biotech and pharmaceutical companies - Nonprofit research organizations - Technology innovators with assets, platforms, or ideas relevant to Roche’s areas of interest - Proposals should demonstrate strong scientific rationale, innovative potential, and alignment with Roche’s strategic partnering interests. - Areas of interest include (but are not limited to): - Cardiovascular, renal, and metabolic diseases - Oncology and hematology - Immunology (inflammatory and autoimmune diseases) - Infectious diseases - Neurology - Ophthalmology - Research technologies (e.g., new mechanisms of action, enabling platforms, AI/ML in drug discovery) - Digital and data-driven healthcare solutions --- ## Application Process - Interested parties should submit a proposal through [Roche’s online partnering portal](https://ppdash.my.site.com/pharmalead/s/genentech-pharma-partnering-leads). - The process typically involves: - Initial proposal submission outlining the innovation, scientific rationale, and potential impact. - Internal review by Roche’s partnering and scientific teams. - Follow-up discussions for promising opportunities. - Negotiation of partnership terms if there is mutual interest. - Additional information and guidance can be found on the [Partner With Us page](https://www.gene.com/partners/partner-with-us). --- ## Additional Information - Roche is particularly interested in transformative, first- or best-in-class innovations that address significant unmet medical needs. - Example partnership models include research collaborations, licensing agreements, co-development, and acquisitions. - Dedicated partnering leads are available for each therapeutic area to guide applicants and facilitate collaboration. --- ## External Links - [Roche Corporate Giving Program](https://www.gene.com/good/giving/corporate-giving) - [What We Are Looking For – Roche Partnering](https://www.gene.com/partners/what-we-are-looking-for) - [Partner With Us – Submit a Proposal](https://ppdash.my.site.com/pharmalead/s/genentech-pharma-partnering-leads) - [For Partners – Genentech](https://www.gene.com/partners) --- ## Contact Information | Name / Role | Contact Page | Notes | |-------------|-------------|-------| | General Partnering Inquiries | [Contact Us](https://www.gene.com/good/giving/contact-us) | Use for questions about eligibility, process, or partnership interests | | Therapeutic Area Partnering Leads | [Partner With Us](https://www.gene.com/partners/partner-with-us) | See area-specific pages for leads in Neurology, Immunology, Oncology, etc. | ---

What We Are Looking For

Sign in to see full grant listing